January 4th, 2011
Due to a high rate of revision surgeries to correct or remove defective implants, DePuy Orthopedics has recalled its ASR XL acetabular hip replacement and resurfacing system. These revision surgeries are painful and expensive and recovery often takes as long as the initial hip surgery. DePuy was alleged to have known that the cup had design problems, but did not warn physicians. In a letter to doctors in March of 2010, DePuy warned of a “higher than expected” failure rate... Read More
Posted in
Current Cases, firm-news |
November 15th, 2010
Working on behalf of consumers who purchased Celexa or Lexapro for their children, lawyers at Pendley, Baudin & Coffin, L.L.P. and Korein Tillery were successful in defeating a motion to dismiss filed by Forest Laboratories, Inc. and Forest Pharmaceuticals, Inc. in Massachusetts federal court. The federal judge presiding over the case, Judge Nathaniel Gorton, ruled that any decisions related to dismissal of the Celexa and Lexapro consumers’ claims are better left for determination at the class certification stage of the... Read More
Posted in
Current Cases, firm-news |
October 14th, 2010
The Chinese Drywall Legal Network announces that a settlement has been reached with Knauf Plasterboard (Tianjin) Co., Ltd. (“KPT”) in the national Chinese drywall litigation pending in New Orleans. In an effort to eventually resolve all of the lawsuits arising from drywall manufactured and exported to the United States by KPT, KPT has agreed to remediate up to 300 homes. This remediation “pilot program” is expected to serve as a model for a possible future global remediation program. Homes eligible... Read More
Posted in
Current Cases, firm-news |
September 9th, 2010
Avastin® (bevacizumab), is the world’s best-selling cancer drug as well as one of the most expensive, sometimes costing patients $100,000 per year or more*. Although many women suffering from breast cancer have relied on the drug to help treat the disease, an FDA panel recently determined that Avastin is not effective in treating breast cancer. In addition, recent studies** show Avastin significantly increased the risk of kidney damage for patients. About Avastin The US Food and Drug Administration (FDA) approved... Read More
Posted in
Current Cases, firm-news |
September 8th, 2010
Louisiana Citizens Property Insurance Corporation is the State of Louisiana’s property insurer of last resort. Each year since Hurricanes Katrina and Rita devastated Louisiana, Citizens has imposed assessments on all property insurance companies operating in the state to help Citizens pay off money borrowed to pay claims related to those hurricanes. In turn, the property insurers passed on these assessments to their policyholders, including homeowner’s and businesses, in Louisiana. These assessments are paid in conjunction with homeowner’s insurance premiums and... Read More
Posted in
Current Cases, firm-news |
August 18th, 2010
Pendley, Baudin & Coffin, L.L.P. is currently evaluating Accutane cases for individuals who have experienced serious adverse side effects including Inflammatory Bowel Disease (IBD), Crohn’s Disease, and Ulcerative Colitis. WHAT IS ACCUTANE? Accutane, the brand name for the drug Isotretinoin (generic), is a medication which was approved by the FDA in 1982 and has been used for the treatment of severe acne. Accutane was originally developed and produced by Hoffman- La Roche and is now produced under many names including... Read More
Posted in
Current Cases, firm-news |
August 12th, 2010
Defective drywall (sheetrock, plasterboard) imported from China during the real estate boom from 2004 – 2006 was used in the construction of new homes. Owners of new homes reported a rotten egg smell and many have been driven from their homes by the obnoxious odor. Homeowners also report corrosion to their air-conditioner coils, pipes, wiring, metal picture frames, etc. Many also complain of respiratory problems, irritated eyes, headaches, nose bleeds and other health problems. It is thought that many builders... Read More
Posted in
Current Cases |
August 12th, 2010
Denial or Underpayment of Benefits under Cancer Insurance Policies Insurance companies are in business to make a profit. Not paying a claim, delaying a claim payment, or offering an inadequate settlement all help to increase their profits at the expense of their policyholders. At Pendley, Baudin & Coffin, L.L.P., we help our clients receive the benefits they need and are entitled to receive under their cancer insurance policies. We are here to help you. Click here or call 225-687-6396 or... Read More
Posted in
Current Cases, firm-news |
August 12th, 2010
These cases arise from the contamination of the long grain rice crops in Texas, Louisiana, Mississippi, Arkansas and Missouri by a genetically modified rice (GMO) that had not been approved for human consumption. Test plots of the rice, LL601, were grown by the Louisiana State University Agriculture Station at Crowley, Louisiana, in what was thought to be an isolated situation. The GMO rice in some way found its way into the commercial rice crops and caused a significant price downturn... Read More
Posted in
Current Cases, firm-news |
August 12th, 2010
This is litigation against the maker of Zurn Pex, Uponor, RTI, Kitec and Marshall Brass plumbing systems. Zurn’s fittings are identified by a Q Pex or a QPex stamped on their side. The homeowners who brought these cases claim that Zurn’s brass fittings were incorrectly designed and manufactured. As a result, the homeowners allege that the Zurn Pex fittings fail prematurely – sometimes only months after installation. Substantial water damage may occur when the fittings fail. Similar failure has occured... Read More
Posted in
Current Cases, firm-news |
